Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions

Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions - Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036641

Enrollment

Registered

2019-05-03

Start date

2017-09-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid lesion

Interventions

EUS-FNA is performed on solid tumors three times using a 22G acquire needle.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants were patients with solid masses (>15mm) who were scheduled to undergo EUS-FNA.

Exclusion criteria

Exclusion criteria: Patients were excluded if they met any of the following criteria: (1) age < 20 years, (2) coagulopathy (international normalized ratio > 1.5 or platelet count < 50,000/mm ), (3) pregnant women, (4) GI obstruction, (5) a European Cooperative Oncology Group performance status of 4.

Design outcomes

Primary

Measure	Time frame
The diagnostic accuracy of histology	—

Secondary

Measure	Time frame
The number of passes for diagnosis Adverse event	—

Countries

Japan

Contacts

Public ContactShinya Uemura

Gifu University Hospital First Dept. of Internal Medicine

ueshin550621@gmail.com058-230-6308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026